Bolt Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BOLT for the last quarter is 5.27 M USD, and it's 152.47% higher compared to the previous quarter. The net income of Q1 24 is -10.81 M USD.